India’s COVID-19 tally has crossed the 65-lakh mark with 75,829 new coronavirus cases and 1,069 deaths reported in the last 24 hours, the Health Ministry data released on Sunday morning shows.
The country now has 65,49,373 total cases of coronavirus, including 9,37,625 active cases and 55,09,766 recoveries. A total of 1,01,782 people have lost their lives to COVID-19 till now.
Meanwhile, India continues to occupy the top global position with the maximum number of COVID-19 recoveries and accounts for 21 per cent of the recovered cases worldwide, while its share in the total cases stands at 18.6 per cent, the Union Health Ministry said. India has also maintained its global position with one of the lowest COVID-19 case fatality rates (CFR) when compared to several other countries.
While the global CFR stands at 2.97 per cent as on date, the comparative figure for India is 1.56 per cent, it said.
Here are the LIVE updates on Coronavirus cases:
For Mumbai’s Dabbawalas, Normalcy Is Distant Even After Unlock
Mumbai’s dabbawalas will now be allowed to board the city’s local trains, according to the government’s unlock guidelines. However, these food-delivery personnel’s troubles may not have ended yet.
Over the six months since they stopped deliveries in the wake of the COVID-19 pandemic, their bicycles have rusted, adding to their expenses even as the customer base shrunk.
“I first used to deliver 25-26 tiffin a day. Now the number is about five. Revenue has gone down. And our cycles have also rusted,” said Shantaram Gargunde, one such dabbawalla.
Since the lockdown, many people have been working from home. Few avail of the tiffin service under the circumstance.
India And South Africa Ask WTO To Waive Rules For COVID-19 Drugs
India and South Africa want the World Trade Organization (WTO) to waive intellectual property rules to make it easier for developing countries to produce or import COVID-19 drugs, a letter to the WTO shows.
In their letter dated October 2 the two countries called on the global trade body to waive parts of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which governs patents, trademarks, copyright and other intellectual property rules globally.
“As new diagnostics, therapeutics and vaccines for COVID-19 are developed, there are significant concerns (over) how these will be made available promptly, in sufficient quantities and at (an) affordable price to meet global demand,” the letter posted on the Geneva-based WTO’s website says.